0001104659-24-029952.txt : 20240301
0001104659-24-029952.hdr.sgml : 20240301
20240301160115
ACCESSION NUMBER: 0001104659-24-029952
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240215
FILED AS OF DATE: 20240301
DATE AS OF CHANGE: 20240301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STERN ADAM K
CENTRAL INDEX KEY: 0001403497
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37704
FILM NUMBER: 24709426
MAIL ADDRESS:
STREET 1: STERN AEGIS VENTURES
STREET 2: 810 7TH AVENUE 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DarioHealth Corp.
CENTRAL INDEX KEY: 0001533998
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 452973162
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 322 W 57TH ST. #33B
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 972-4-770-6377
MAIL ADDRESS:
STREET 1: 322 W 57TH ST. #33B
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: LabStyle Innovations Corp.
DATE OF NAME CHANGE: 20111101
4
1
tm247605-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-15
0
0001533998
DarioHealth Corp.
DRIO
0001403497
STERN ADAM K
18 W. 18TH ST,
5TH FLOOR
NEW YORK
NY
10011
1
0
0
0
0
Series-C Preferred Stock
2.02
2024-02-15
4
A
0
250
1000
A
Common Stock
250
I
AKS Family Partnership, L.P
Subject to beneficial ownership limitations provided for in the offering documents relating to the sale of the Series-C Preferred Stock, each share of Series-C Preferred Stock shall automatically convert into shares of the registrant's common stock at the conversion price of $2.02 upon the earlier of (i) the 15-month anniversary of the effective date of the certificate of designation, or (ii) the consent to conversion by holders of at least 50.1% of the outstanding shares of Series-C Preferred.
The Series C Preferred Stock initially converts into shares of common stock at a conversion price of $2.02. In addition, the holders of Series c Preferred Stock will also be entitled dividends payable as follows: (i) a number of shares of Common Stock equal to seven and a half percent (7.5%) of the number of shares of Common Stock issuable upon conversion of the Series C Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the closing date, and (ii) a number of shares of common stock equal to fifteen percent (15%) of the number of shares of common stock issuable upon conversion of the Series C Preferred Stock then held by such holder on the fifth full quarter from the closing date.
/s/ Adam Stern
2024-03-01